Most people have heard of vitamin D for bones and vitamin C for immunity. But there is a fat-soluble nutrient quietly pulling the strings behind calcium metabolism, cardiovascular protection, and skeletal integrity - and the vast majority of the Western population is not getting enough of it. Vitamin K2, also known as menaquinone, is rapidly emerging as one of the most underappreciated nutrients in modern nutrition science.
Here is the core problem: your body absorbs calcium from food and supplements, but without proper direction, that calcium can end up in the wrong places. It deposits in arterial walls, contributing to heart disease. It accumulates in soft tissues, causing stiffness and dysfunction. Meanwhile, your bones - the place that actually needs it - are slowly losing density. This phenomenon is called the “calcium paradox,” and vitamin K2 deficiency sits at its center [1]. Getting enough K2 is the difference between calcium strengthening your skeleton and calcium hardening your arteries.
This guide covers everything you need to know about vitamin K2 - from the biochemistry of how it works, to the clinical evidence behind its benefits, to the best vitamin K2 foods and supplements to incorporate into your routine.
How Vitamin K2 Works in Your Body
Vitamin K is a family of fat-soluble compounds divided into two primary categories. Vitamin K1 (phylloquinone) comes from plant sources - mainly leafy green vegetables like kale, spinach, and collard greens. Vitamin K2 (menaquinone) is found in animal-sourced foods and fermented products, and is also synthesized by certain intestinal bacteria [2].
While K1 and K2 share a similar chemical backbone, they behave very differently once absorbed. The liver rapidly takes up most K1 and uses it to activate blood-clotting factors - proteins II, VII, IX, and X plus prothrombin [3]. K2, by contrast, is released from the liver into the bloodstream, where it reaches extrahepatic tissues like bone, cartilage, and the arterial wall [4].
The Gamma-Carboxylation Engine
At the molecular level, all forms of vitamin K serve as a cofactor for the enzyme gamma-glutamyl carboxylase. This enzyme converts specific glutamic acid residues in proteins to gamma-carboxyglutamic acid (Gla) residues - a modification that gives these proteins the ability to bind calcium [5]. Without this carboxylation step, calcium-dependent proteins remain inactive and unable to do their jobs.
Two vitamin K-dependent proteins (VKDPs) are particularly relevant to the K2 story:
Osteocalcin is produced by osteoblasts (bone-building cells) and is the most abundant non-collagenous protein in bone matrix. When carboxylated by vitamin K2, osteocalcin binds calcium and incorporates it into the hydroxyapatite crystal structure of bone, directly contributing to bone mineral density and strength [6]. Uncarboxylated osteocalcin (ucOC) - the inactive form - is a reliable biomarker of poor vitamin K status and has been linked to increased fracture risk.
Matrix Gla Protein (MGP) is one of the most potent natural inhibitors of soft-tissue calcification [7]. When carboxylated by vitamin K2, MGP actively prevents calcium from depositing in arterial walls, heart valves, and other soft tissues. When vitamin K2 is insufficient, MGP remains uncarboxylated and inactive, allowing calcium to accumulate where it shouldn’t - a direct pathway to vascular calcification and cardiovascular disease.
The Calcium Paradox Explained
The term “calcium paradox” describes a situation where calcium is simultaneously lacking in bone (leading to osteoporosis) while accumulating in blood vessel walls (leading to arterial calcification) [1]. These two conditions - osteoporosis and vascular calcification - share overlapping etiopathogenetic mechanisms, and vitamin K2 deficiency may be responsible for both occurring in the same individual at the same time.
Think of K2 as a calcium traffic cop. Vitamin D increases calcium absorption from the gut into the bloodstream - which is essential - but D alone cannot direct where that calcium goes [8]. K2 steps in to activate the proteins that shuttle calcium into bone and keep it out of arteries. Without adequate K2, the increased calcium load from vitamin D supplementation may actually accelerate arterial calcification rather than improve bone health. This is why vitamin K2 and vitamin D are increasingly recognized as a package deal rather than separate nutrients.
K1 Versus K2: More Than Just Subtypes
Despite sharing the “vitamin K” label, K1 and K2 have distinct tissue distributions, half-lives, and physiological roles. Smaller vitamin K molecules like K1 are cleared from the body within approximately 1.5 hours [9]. The largest K2 molecules - particularly MK-7 - remain in circulation for several days, giving them much more time to reach and activate extrahepatic proteins in bone and vascular tissue.
The body can convert some K1 to K2, and gut bacteria produce limited amounts of K2 (primarily longer-chain forms like MK-10 and MK-11 in the colon, where absorption is minimal) [10]. But these endogenous sources appear insufficient for optimal activation of all vitamin K-dependent proteins outside the liver. Approximately 35% of the U.S. population does not meet even the current adequate intake for vitamin K [11], and many researchers argue the current recommendations - which are based solely on maintaining normal blood clotting - are too low for bone and cardiovascular protection [4].
A growing body of evidence supports establishing a separate recommended daily intake for K2, distinct from K1, given their different metabolic fates and physiological roles [4].
MK-7 Vitamin K2: The Preferred Menaquinone Form
Vitamin K2 encompasses a family of related compounds designated MK-1 through MK-13, where the number represents the length of the isoprenoid side chain [12]. Of these, two forms dominate the research and supplement landscape: MK-4 (menaquinone-4) and MK-7 (menaquinone-7).
MK-4: The Short-Chain Form
MK-4 is found naturally in animal-sourced foods - butter from grass-fed cows, egg yolks, liver, chicken, and some cheeses. It is also the form that human tissues synthesize from K1 via the enzyme UBIAD1 [13]. MK-4 has preferential distribution to certain tissues including the brain, kidneys, and skeletal muscle, making it potentially important for neurological function [14].
However, MK-4 has a short half-life - similar to K1 - meaning it is rapidly cleared from the bloodstream. Therapeutic doses used in Japanese osteoporosis trials typically range from 15 to 45 mg per day, which is hundreds of times higher than the microgram-level doses used for MK-7 [15]. This pharmacological dosing requirement makes MK-4 less practical for daily supplementation aimed at general health maintenance.
Why MK-7 Vitamin K2 Dominates Supplementation
MK-7 - the vitamin K2 menaquinone-7 form - has emerged as the preferred supplemental form for several reasons:
Superior bioavailability. Both MK-7 and K1 are well absorbed, with peak serum concentrations appearing about 4 hours after intake. But the critical difference is half-life: MK-7’s much longer half-life results in stable serum levels and 7- to 8-fold higher accumulation during prolonged intake compared to equivalent doses of K1 [16]. This means MK-7 provides sustained, around-the-clock activation of vitamin K-dependent proteins rather than brief spikes followed by rapid clearance.
Greater potency at low doses. MK-7 induced more complete carboxylation of osteocalcin than K1 in direct comparison studies [16]. One landmark study demonstrated that natto-derived MK-7 increased the percentage of carboxylated osteocalcin in humans three times more powerfully than vitamin K1 [17]. This superior potency means meaningful clinical effects can be achieved at doses of 100-200 mcg per day - a thousandth of the MK-4 doses used in Japanese trials.
Dose-dependent MGP activation. In a randomized, double-blind, placebo-controlled trial, 12 weeks of MK-7 supplementation at 180 mcg and 360 mcg per day reduced desphosphorylated-uncarboxylated MGP (dp-ucMGP, a marker of vascular vitamin K deficiency) by 31% and 46%, respectively [18]. This dose-dependent reduction in inactive MGP translates directly to improved vascular calcification inhibition.
Long-term bone protection. A three-year randomized controlled trial in 244 healthy postmenopausal women found that 180 mcg of MK-7 per day significantly decreased the age-related decline in bone mineral content and bone mineral density at the lumbar spine and femoral neck, while also favorably affecting bone strength indices [19]. These are the types of long-duration outcomes that matter most for osteoporosis prevention.
The average Western diet provides only about 10-30 mcg of vitamin K2 per day [12], which is well below the doses shown to produce meaningful clinical effects. This gap between dietary intake and therapeutic thresholds is the primary argument for MK-7 supplementation.
Vitamin K2 with D3 Benefits: Why They Work Best Together
The synergy between vitamin K2 and vitamin D is one of the most important nutrient partnerships in human physiology. Understanding this relationship is essential for anyone taking vitamin D supplements - which, given the widespread prevalence of vitamin D insufficiency, includes a substantial portion of the population.
The Complementary Mechanism
Vitamin D3 (cholecalciferol) increases intestinal calcium absorption by 30-40% [8]. This is its primary job - making sure your body actually captures the calcium you eat. But getting calcium into the bloodstream is only step one. Without a mechanism to direct that calcium appropriately, elevated blood calcium can deposit in arteries, kidneys, and other soft tissues.
This is where K2 enters the picture. Vitamin D3 promotes the production of vitamin K-dependent proteins - specifically osteocalcin and MGP - but these proteins require vitamin K2 for activation via carboxylation [20]. In other words, vitamin D3 creates the demand for vitamin K2. D3 builds the workforce; K2 gives it the tools to function.
A review published in the International Journal of Endocrinology concluded that combined supplementation with vitamins D and K can be more effective in promoting bone and cardiovascular health compared to either vitamin used alone [20]. The two nutrients are, in a real biochemical sense, designed to work as a unit.
The Vitamin D Toxicity Connection
One of the most provocative hypotheses in vitamin research proposes that vitamin D toxicity is fundamentally a vitamin K deficiency in disguise [21]. The reasoning: high-dose vitamin D increases expression of vitamin K-dependent proteins, which accelerates the consumption of available vitamin K. As the vitamin K pool depletes, proteins like MGP can no longer be carboxylated, leading to the soft tissue calcification, bone resorption, and other symptoms classically attributed to hypervitaminosis D.
Animal studies support this model - vitamin K-deficient animals and animals fed toxic doses of vitamin D exhibit remarkably similar symptom profiles [21]. Warfarin (which inhibits vitamin K recycling) and excessive vitamin D exert toxicity synergistically when combined. This has practical implications: if you are supplementing with vitamin D - particularly at doses above 2,000 IU - co-supplementation with vitamin K2 provides a critical safety buffer for calcium metabolism.
Practical Dosing for the D3-K2 Combination
The ideal ratio of D3 to K2 is still debated, but clinical practice and research provide useful guidelines. Many practitioners recommend approximately 100 mcg of MK-7 for every 5,000 IU of D3 [22]. Some experts suggest a broader rule of pairing K2 at roughly 1/10th the IU count of your D3 dose (so 200 mcg K2 for 2,000 IU D3).
For individuals whose 25(OH)D blood levels are above 70 ng/mL, adding vitamin K2 becomes especially important to regulate the increased calcium load [22]. Research suggests taking 100 mcg daily or 800 mcg weekly of MK-7 alongside vitamin D3 to prevent calcium buildup in arteries.
Liquid combination formulas - such as those providing 1,000 IU D3 plus 120 mcg K2 per drop - offer precise dose titration and ensure you never take one without the other [23].
Benefits of Vitamin K2 and D3 for Bone Health
Bone is not a static structure. It undergoes constant remodeling - osteoclasts break down old bone while osteoblasts build new bone. This cycle requires precise regulation of calcium deposition, and vitamin K2 plays a central role in ensuring calcium reaches the right place.
Osteocalcin: The Bone-Building Protein
Osteocalcin is the primary non-collagenous protein in bone matrix, and its production by osteoblasts depends on adequate vitamin D [6]. But production alone is not enough - osteocalcin must be carboxylated by vitamin K2 to become biologically active and capable of binding calcium into the hydroxyapatite crystal structure of bone. High levels of undercarboxylated osteocalcin (ucOC) indicate that bones are not efficiently incorporating calcium, even when calcium intake is adequate.
There is also a fascinating secondary story: when osteocalcin is later released from bone matrix, it circulates as an endocrine hormone that optimizes insulin secretion, insulin sensitivity, fuel utilization during exercise, and male testosterone production [24]. K2 helps lock osteocalcin into bone matrix first, and the body releases it from bone on demand through decarboxylation when those metabolic signals are needed.
Clinical Trial Evidence
The evidence for vitamin K2’s bone-protective effects is strongest in postmenopausal women, the population most vulnerable to osteoporosis.
In a landmark three-year trial, 244 healthy postmenopausal women receiving 180 mcg/day of MK-7 showed significantly less decline in bone mineral density at the lumbar spine and femoral neck compared to placebo. Bone strength indices of the femoral neck were also favorably affected, and the MK-7 group showed significantly less loss of vertebral height - a measure of compression fracture risk [19].
A meta-analysis of 19 randomized controlled trials encompassing 6,759 participants found that vitamin K2 may maintain bone mineral density and reduce fracture incidence in postmenopausal women with osteoporosis. Subgroup analysis revealed significant improvement in vertebral BMD for both medium-term and long-term results. When one heterogeneity-inducing study was removed from the fracture analysis, the remaining studies showed a significant 50% reduction in fracture incidence [25].
Japanese studies using pharmacological doses of MK-4 (45 mg/day) in 241 osteoporotic patients showed that vitamin K2 effectively prevented fractures and sustained lumbar bone mineral density over 24 months. The treated group experienced significantly fewer clinical fractures than controls [26].
Even low-dose MK-4 supplementation (1.5 mg/day) for 12 months improved bone quality markers and prevented forearm bone loss in postmenopausal Japanese women, as measured by decreased ucOC and pentosidine concentrations without adverse effects [27].
It is worth noting that not all trials have shown positive results. A 12-month study in early menopausal Norwegian women using 360 mcg MK-7 as natto capsules found no effect on bone loss rates, despite successful improvement in vitamin K status markers [28]. The discrepancy may relate to differences in population characteristics, baseline vitamin K status, duration of supplementation, and the stage of menopause. Three-year trials appear more likely to capture bone density changes than 12-month studies, given the slow rate of bone remodeling.
The European Food Safety Authority accepted the health claim that vitamin K contributes to the maintenance of normal bone health - an endorsement based on the totality of available evidence [19].
How Vitamin K2 Protects Your Cardiovascular System
Cardiovascular disease remains the leading cause of death globally, and arterial calcification is one of its strongest predictors. Calcium deposits in coronary arteries stiffen vessels, promote plaque formation, and significantly increase heart attack risk. Vitamin K2 is one of the few nutrients with a clear biological mechanism for preventing this calcification process.
Matrix GLA Protein: Your Anti-Calcification Shield
Matrix Gla Protein (MGP) is synthesized in vascular smooth muscle cells and chondrocytes. When activated by vitamin K2-dependent carboxylation, MGP is one of the most potent inhibitors of vascular calcification known [7]. It essentially acts as a molecular scavenger that binds calcium crystals before they can embed in arterial walls.
When vitamin K2 status is inadequate, MGP remains uncarboxylated and unable to perform this protective function. Elevated levels of inactive dp-ucMGP in the blood serve as a reliable biomarker of both vitamin K deficiency and increased cardiovascular risk [18].
In hemodialysis patients - a population suffering from accelerated vascular calcification - baseline dp-ucMGP levels were 4.5-fold higher than healthy controls. Vitamin K2 (MK-7) supplementation produced dose- and time-dependent decreases in dp-ucMGP, with response rates of 77% at 45 mcg/day and improving further at higher doses [29]. This represents measurable improvement in the body’s calcification defense system.
Epidemiological Evidence
A 2019 meta-analysis pooling 21 studies and 222,592 participants found that increased dietary intake of vitamin K (both K1 and K2) was linked to a moderately reduced risk of coronary heart disease [3]. A separate review noted that K2 showed the most promise of the two forms, consistent with K2’s preferential distribution to extrahepatic tissues where arterial calcification occurs.
Cross-sectional and cohort studies consistently show that higher vitamin K status is associated with reduced coronary artery calcification, lower cardiovascular disease incidence, and decreased mortality risk [30]. The EPIC-Heidelberg data revealed meaningful associations between dietary vitamin K2 intake and cardiovascular protection that were not observed with K1 alone.
An increase in dietary vitamin K intake was associated with a reduced risk of dying from all causes in a Mediterranean population of over 7,200 participants at high cardiovascular disease risk [31]. This all-cause mortality finding is notable - vitamin K2 is one of the few supplements where observational data actually suggests a relationship with reduced overall death risk.
A Note on Study Limitations
Most of the cardiovascular evidence comes from observational studies, which can demonstrate association but not causation. Long-term randomized controlled trials specifically examining cardiovascular endpoints with K2 supplementation are still needed [3]. However, the biological mechanism is well-established and highly plausible: K2 activates MGP, MGP prevents calcification, and calcification drives heart disease. The chain of evidence is internally consistent.
Vitamin K2 Foods: The Best Dietary Sources
Getting vitamin K2 from food is ideal, but the challenge is that K2 is found in a much narrower range of foods than K1. While K1 is abundant in virtually any green vegetable, vitamin K2 foods are limited primarily to animal products and fermented items - many of which are absent from a standard Western diet.
Natto: The Vitamin K2 Powerhouse
No discussion of vitamin K2 rich foods is complete without natto. This traditional Japanese fermented soybean product contains the highest concentration of vitamin K2 of any food ever measured - approximately 998 mcg per 100 grams, nearly all in the MK-7 form [32]. A single ounce of natto provides 283 mcg of vitamin K, which is 238% of the Daily Value.
The connection between natto vitamin K2 content and population health is compelling. Japan, where natto consumption is common, has historically shown a lower incidence of hip fractures compared to Western countries. Multiple studies have attributed this in part to natto’s contribution to vitamin K2 intake [33].
Natto is produced through fermentation of soybeans by Bacillus subtilis bacteria. This same organism produces nattokinase, a fibrinolytic enzyme with potent blood-clot-dissolving properties that has been studied for cardiovascular applications including atherothrombotic prevention [34]. So natto delivers a one-two punch: vitamin K2 nattokinase benefits come bundled in the same food - K2 prevents arterial calcification while nattokinase helps dissolve existing clots.
The catch: natto has a pungent smell and slimy texture that many people outside of Japan find unpalatable. If you can acquire the taste, it is by far the most efficient whole-food source of MK-7. If not, fermented soybean extracts and MK-7 supplements derived from natto are widely available.
Vitamin K2 Rich Foods from Animal Sources
Animal-sourced foods contain vitamin K2 primarily as MK-4:
Goose liver pate is one of the richest animal sources, providing substantial MK-4 per serving. Other organ meats - particularly beef and chicken liver - are good sources. Organ meats were staples in traditional diets but have largely disappeared from modern Western eating patterns, contributing to widespread K2 insufficiency.
Grass-fed butter and dairy deserve special mention. The vitamin K2 content of butter varies dramatically - up to 50-fold - depending on what the animals eat [17]. Cows grazing on vitamin K1-rich green pastures convert K1 to K2 and concentrate it in their fat. Butter from grain-fed, feedlot-raised cattle (the overwhelming majority sold in the U.S.) contains minimal K2. Grass-fed butter, hard aged cheeses from grass-fed animals, and egg yolks from pastured hens are meaningfully better sources.
Egg yolks contain moderate amounts of MK-4, with pastured eggs providing more than conventional eggs. Dark chicken meat also contributes small amounts.
Cheese - particularly hard, aged varieties - can be a notable K2 source. Gouda and Brie tend to contain higher levels than softer cheeses, as the bacterial cultures involved in aging produce menaquinones [35]. The MK-8 and MK-9 forms are prevalent in cheese.
Fermented Foods High in Vitamin K2
Beyond natto, vitamin K2 in fermented foods comes from bacterial synthesis during the fermentation process. Several microorganisms used in food fermentation - including Bacillus subtilis, Propionibacterium freudenreichii, and certain lactic acid bacteria - produce meaningful amounts of vitamin K2 [36].
Sauerkraut contains K2 due to the lactic acid fermentation of cabbage. The amounts are modest compared to natto but contribute to overall intake, especially when consumed regularly.
Kefir is increasingly recognized as a functional K2 source. The diverse bacterial cultures in kefir produce K2 during fermentation, and regular consumption provides cumulative benefit [37].
Miso and other fermented soybean products contain varying amounts of K2 depending on the specific bacterial strains involved in production.
Fermented cheeses - as mentioned above - represent perhaps the most palatable source of fermented K2 for Western diets. Aged Gouda, Jarlsberg, Edam, and similar hard cheeses made with specific bacterial cultures can provide meaningful K2 contributions.
The broader implication is relevant: traditional diets around the world included substantially more fermented foods and organ meats than modern Western diets. The shift away from these foods has quietly created a widespread subclinical K2 deficiency that doesn’t show up on standard blood tests (since clotting function - a K1-dependent process - typically remains normal) but may be contributing to the high rates of osteoporosis and cardiovascular disease in developed nations [7].
Beyond Bones and Heart: Additional Vitamin K2 Benefits
While bone and cardiovascular health dominate the K2 research landscape, this nutrient’s biological reach extends considerably further. Here is what the evidence shows across several additional domains.
Mitochondrial Function and Energy Production
One of the most fascinating discoveries about vitamin K2 is its role as a mitochondrial electron carrier. In a groundbreaking study published in Science, researchers found that vitamin K2 was necessary and sufficient to transfer electrons in Drosophila mitochondria - functioning in a manner similar to ubiquinone (CoQ10) [13]. Mutants with defective mitochondria showed severe dysfunction that was rescued by vitamin K2, which restored normal ATP production.
This finding has direct relevance to energy metabolism. Mitochondria are the power plants of every cell in your body, and any nutrient that supports electron transport chain efficiency has the potential to influence energy levels, exercise performance, and cellular resilience. The mitochondrial role is specific to K2 - K1 does not serve this bioenergetic function [38].
Exercise Performance and Cardiac Output
Building on the mitochondrial connection, a randomized controlled trial in 26 aerobically trained male and female athletes found that 8 weeks of vitamin K2 supplementation was associated with increased maximal cardiac output during graded exercise testing [39]. The proposed mechanism: K2-dependent improvements in mitochondrial function within cardiac muscle - which has exceptionally high mitochondrial density - may enhance the heart’s pumping capacity during peak exertion.
This is early-stage evidence with a small sample, but it aligns with the established biochemistry of K2’s electron carrier function and opens an interesting avenue for sports performance research.
Insulin Sensitivity and Metabolic Health
Vitamin K2 supplementation for 4 weeks increased insulin sensitivity in 33 healthy young men [31]. This effect may operate through multiple pathways: osteocalcin (when released from bone in its undercarboxylated form) acts as an endocrine hormone that improves insulin secretion and sensitivity [24], and K2 may directly influence glucose and lipid metabolism.
A randomized controlled trial in 102 patients with type 2 diabetes found that 6 months of yogurt fortified with 90 mcg/day of K2 significantly improved grip strength, skeletal muscle mass, gait speed, HbA1c, fasting blood glucose, fasting insulin, and HOMA-IR compared to control yogurt [40]. K2 alleviated insulin resistance-associated skeletal muscle atrophy through activation of the AKT/mTOR signaling pathway - a critical regulator of muscle protein synthesis.
This muscle-metabolic connection is particularly relevant for aging populations and anyone dealing with insulin resistance, where the progressive loss of muscle mass (sarcopenia) and metabolic dysfunction create a vicious cycle that K2 may help interrupt.
Brain Health and Neuroprotection
Vitamin K2 (specifically MK-4) is present in high concentrations in the brain, where it participates in the synthesis of sphingolipids - a class of lipids critical for myelin sheath integrity and cell signaling [14]. K2 also activates the brain protein Gas6, which controls cell growth, survival, and apoptosis. Adequate K2 status has been correlated with better focus and memory function.
In animal models, vitamin K2 ameliorated experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis. The severity of the condition was significantly reduced by prophylactic K2 administration, with reduced inflammatory cell infiltration and decreased expression of both MHC class II molecules and inducible nitric oxide synthase (iNOS) in spinal cord tissue [41]. These anti-inflammatory effects in the central nervous system suggest neuroprotective potential, although human trials are needed.
K2 has also been linked to broader age-related cognitive protection. A review in Nutrients highlighted vitamin K’s emerging role in chronic low-grade inflammatory diseases including dementia and cognitive impairment [42].
Anti-Inflammatory and Autoimmune Effects
The anti-inflammatory properties of K2 extend beyond the nervous system. In a study of 158 female rheumatoid arthritis patients, those treated with vitamin K2 (45 mg/day MK-4) showed significantly lower serum C-reactive protein (CRP), MMP-3, and disease activity scores compared to K2-naive patients. A longitudinal sub-study confirmed that adding K2 to existing medication regimens produced significant decreases in inflammatory markers within three months [43].
A recent randomized controlled trial provided compelling evidence for K2’s anti-inflammatory effects in Long COVID patients. Adults with persistent symptoms received 240 mcg MK-7 plus 2,000 IU vitamin D3 daily for 24 weeks. The treatment group showed significant improvements in Long COVID symptoms, reductions in fungal translocation markers, and decreased systemic inflammation compared to standard of care [44]. This trial suggests the D3-K2 combination may have broad anti-inflammatory utility beyond traditional bone and cardiovascular applications.
Cancer: Preliminary but Interesting
The European Prospective Investigation into Cancer and Nutrition (EPIC) revealed that increased intake of vitamin K2 may reduce the risk of prostate cancer by 35% in a cohort of over 11,000 men. The benefits were most pronounced for advanced prostate cancer, and notably, vitamin K1 did not offer similar protection [31].
An increase in dietary vitamin K (both K1 and K2) was associated with two times lower cancer mortality in over 7,000 study participants [31]. A review of 6 clinical trials involving 930 patients suggested that K2 supplementation may improve overall survival and reduce recurrence of liver cancer after surgery, though beneficial effects were observed only at 2- and 3-year follow-up [31].
These findings are preliminary and do not support using K2 as a cancer treatment. But they contribute to a broader picture of K2 as a nutrient with systemic health implications beyond its classical roles.
Skin Health
Vitamin K2 is necessary for the proper functioning of vitamin A- and D-dependent proteins. Since vitamin A is essential for proper skin cell proliferation, vitamin K2 deficiency may contribute to skin conditions linked to vitamin A dysfunction - including acne, keratosis pilaris, and premature wrinkling [45]. People who cannot metabolize vitamin K tend to develop severe premature skin wrinkling, suggesting a direct mechanistic role in maintaining skin elasticity and structure.
Fat Metabolism and Longevity
In C. elegans models, vitamin K2 extended lifespan and improved resistance to pathogen infection, heat stress, and oxidative stress. Importantly, these effects were shown to depend on enhanced fat metabolism - not antioxidant activity [46]. K2 significantly upregulated genes related to fatty acid elongation, desaturation, and beta-oxidation, suggesting it actively promotes fat degradation. While worm models are far from human clinical evidence, the finding is consistent with K2’s observed metabolic effects in mammalian systems and supports the broader hypothesis that K2 influences energy metabolism at a fundamental level.
Best Vitamin K2 Supplement: How to Choose
With a clear understanding of K2’s benefits, the practical question becomes: what should you actually buy? The supplement market offers numerous K2 products, and quality varies significantly. Here is what to evaluate.
MK-7 vs. MK-4: Which Form to Supplement
For general health maintenance - bone protection, cardiovascular support, and metabolic health - MK-7 is the superior supplemental form for most people. Its longer half-life, greater bioavailability, and proven efficacy at low microgram doses make it the most practical choice [16].
MK-4 has value in specific clinical contexts. Its preferential distribution to brain, kidneys, and skeletal muscle makes it potentially relevant for neurological health and conditions where high tissue concentrations are needed [23]. Japanese clinical practice uses 45 mg/day MK-4 for osteoporosis treatment - a pharmacological dose that delivers measurable bone protection [26]. If you are specifically targeting bone density under medical supervision, high-dose MK-4 is an evidence-based option.
Some clinicians advocate combining both forms: a baseline dose of MK-7 (100-200 mcg) for sustained whole-body K2 activity, plus lower-dose MK-4 for tissue-specific benefits. Products combining K1, MK-4, and MK-7 are available and provide the broadest spectrum of vitamin K activity.
Dosing Guidelines
There is no established tolerable upper intake level (UL) for vitamin K because no toxicity has been identified for natural K1 or K2 forms at any studied dose [3]. This gives a wide safety margin for supplementation.
Based on the available clinical evidence:
- Minimum effective dose for MK-7: 100 mcg/day. This exceeds the current adequate intake (90-120 mcg for all vitamin K forms combined) and has demonstrated effects on vitamin K status markers.
- Optimal range for most adults: 180-300 mcg/day MK-7. The three-year bone density trial used 180 mcg [19]. Thomas DeLauer and other practitioners recommend 300 mcg for active individuals [47].
- Higher doses for specific conditions: Hemodialysis patients showed dose-dependent benefit up to 1,080 mcg MK-7 three times weekly [48]. The Long COVID trial used 240 mcg MK-7 daily [44]. These higher doses appear safe but should be discussed with a healthcare provider.
- With vitamin D3: 100 mcg MK-7 per 5,000 IU D3 is a commonly recommended ratio.
What to Look For on the Label
All-trans MK-7. This is the naturally occurring, fully bioactive form identical to the K2 molecule found in nature. Some synthetic processes produce a mix of trans and cis isomers, where the cis form has minimal biological activity [12]. Look for products specifying ≥99% all-trans MK-7.
Third-party testing. USP verification, NSF certification, or documented in-house testing protocols provide assurance that the product contains what the label claims and is free from contaminants. Nature Made’s K2 product, for example, is USP verified [49]. Thorne and Transparent Labs use rigorous in-house and third-party testing.
Fat-soluble delivery. Vitamin K2 is fat-soluble, meaning absorption is enhanced when consumed with dietary fat. Softgels containing a small amount of oil (MCT oil, olive oil) may offer better absorption than dry capsules. Liquid formulations taken with meals are another option.
Combined D3+K2 products. For simplicity and compliance, combination products ensure you never take D3 without K2. Look for products providing at least 100 mcg MK-7 alongside 1,000-5,000 IU D3. Transparent Labs, Thorne, and several other brands offer well-formulated combination softgels.
Side Effects of Vitamin K2 with D3
The safety profile of vitamin K2 is excellent. Natural forms of vitamin K have very low toxicity potential, which is why no UL has been established [3].
However, there are important considerations when combining vitamin K2 with D3:
Blood thinner interactions. This is the primary safety concern. Vitamin K directly counteracts the mechanism of warfarin (Coumadin) and similar vitamin K antagonist anticoagulants. Doses of MK-7 at 50 mcg/day or above may interfere with anticoagulant therapy in a clinically relevant way [16]. If you are taking warfarin or other blood thinners, do not supplement with vitamin K2 without explicit guidance from your prescribing physician. Even dietary changes that significantly alter vitamin K intake should be discussed with your doctor.
Hypercalcemia risk from excessive D3. While K2 itself does not cause hypercalcemia, excessive vitamin D3 can raise blood calcium levels dangerously - leading to nausea, kidney problems, fatigue, and confusion [22]. K2 helps mitigate some of this risk by directing calcium appropriately, but it cannot fully compensate for extreme D3 overdose. Keep D3 dosing reasonable (most people need 2,000-5,000 IU) and monitor blood levels periodically, particularly if dosing above 5,000 IU.
Gastrointestinal effects. In the hemodialysis dose-finding study using high-dose MK-7, the primary reason for dropout was gastrointestinal side effects related to the unpleasant smell of the tablets [48]. At standard supplemental doses (100-300 mcg), GI complaints are rare.
No known K2 toxicity. Multiple reviews confirm that vitamin K2 has no identified toxicity at any naturally occurring dose. The synthetic form menadione (vitamin K3) can cause adverse effects at high doses, but K3 is not used in modern dietary supplements [3].
Medication interactions beyond warfarin. Broad-spectrum antibiotics can disrupt gut bacteria that produce some endogenous K2, potentially worsening vitamin K status over time [10]. Very high doses of vitamin A may reduce vitamin K absorption, and mega-doses of vitamin E may counteract vitamin K’s blood clotting effects [50]. These interactions are relevant at extreme doses but are unlikely to matter at typical supplemental levels.
The bottom line: for the vast majority of people not taking vitamin K antagonist anticoagulants, vitamin K2 supplementation at 100-300 mcg per day is safe, well-tolerated, and supported by clinical evidence. When paired with vitamin D3 at appropriate doses, the combination offers synergistic benefits with minimal risk.
Who Should Prioritize Vitamin K2
While K2 has broad relevance, certain populations stand to benefit most:
Postmenopausal women face accelerated bone loss due to declining estrogen. After menopause, approximately one in two women will break a bone due to osteoporosis [20]. K2 supplementation is a proactive strategy for preserving bone density and strength.
Anyone supplementing vitamin D. If you take D3 without K2, you may be inadvertently promoting calcium deposition in soft tissues. The higher your D3 dose, the more important co-supplementation with K2 becomes.
People with limited fermented food intake. If natto, aged cheese, sauerkraut, and organ meats are not regular features of your diet - and for most Westerners, they are not - dietary K2 intake is likely inadequate.
Individuals with kidney disease. Hemodialysis patients show dramatically elevated markers of vitamin K deficiency and accelerated vascular calcification. K2 supplementation significantly improves their vitamin K status [29].
Active individuals and athletes. The mitochondrial electron carrier function of K2, combined with preliminary evidence of improved cardiac output, suggests potential performance benefits worth investigating [39].
Those at cardiovascular risk. Anyone with established arterial calcification, family history of heart disease, or elevated coronary artery calcium scores should discuss K2 supplementation with their cardiologist.
Frequently Asked Questions About Vitamin K2
What Is Vitamin K2?
Vitamin K2, also known as menaquinone, is a fat-soluble vitamin found primarily in animal-sourced foods and fermented products. It belongs to the vitamin K family but differs from vitamin K1 (found in leafy greens) in its tissue distribution, half-life, and physiological roles. K2 exists in several subtypes, the most important being MK-4 and MK-7, which differ in their side chain length, bioavailability, and optimal dosing [4].
What Does Vitamin K2 Do?
Vitamin K2 activates calcium-binding proteins that control where calcium goes in your body. It carboxylates osteocalcin to deposit calcium into bone, and it carboxylates matrix Gla protein to prevent calcium from accumulating in arteries and soft tissues [7]. Beyond calcium metabolism, K2 serves as a mitochondrial electron carrier that supports cellular energy production [13], and it activates brain proteins involved in myelination and cell signaling.
What Is Vitamin K2 Good For?
The strongest evidence supports K2 for maintaining bone mineral density, preventing arterial calcification, and supporting cardiovascular health. Additional research suggests benefits for insulin sensitivity, exercise performance, anti-inflammatory effects, brain health, and skin integrity. K2 is also critical for anyone taking vitamin D supplements, as it ensures the increased calcium absorption from D3 is properly directed to bones rather than soft tissues [20].
Can You Take Too Much Vitamin K2?
No toxicity has been identified for natural forms of vitamin K2 at any studied dose. There is no established tolerable upper intake level [3]. However, individuals on warfarin or other vitamin K antagonist anticoagulants must carefully manage vitamin K intake under medical supervision, as K2 can interfere with these medications’ mechanism of action [16].
Should You Take Vitamin K2 Every Day?
Daily supplementation with MK-7 provides the most stable blood levels due to its longer half-life and accumulation properties [16]. Taking K2 with a fat-containing meal enhances absorption. Consistency matters more than timing - the goal is to maintain sufficient K2 status to keep osteocalcin and MGP adequately carboxylated around the clock.
Compare Alternatives
References
Fusaro, M., et al. “Something more to say about calcium homeostasis: the role of vitamin K2 in vascular calcification and osteoporosis.” European Journal of Clinical Investigation. (https://pubmed.ncbi.nlm.nih.gov/24089220/)
Healthline. “Here’s how Vitamin K2 Supports Your Body and How to Get It.” (https://www.healthline.com/nutrition/vitamin-k2)
Healthline. “Here’s how Vitamin K2 Supports Your Body and How to Get It.” (https://www.healthline.com/nutrition/vitamin-k2)
Akbulut, A.C., et al. “Vitamin K2 Needs an RDI Separate from Vitamin K1.” Nutrients, 12(6). (https://pubmed.ncbi.nlm.nih.gov/32575901/)
SelfHacked. “7 Vitamin K2 Health Benefits + Foods & Deficiency Risks.” (https://selfhacked.com/blog/top-10-science-based-benefits-vitamin-k2)
Aaseth, J.O., et al. “The Importance of Vitamin K and the Combination of Vitamins K and D for Calcium Metabolism and Bone Health: A Review.” Nutrients, 16(15). (https://pubmed.ncbi.nlm.nih.gov/39125301/)
Maresz, K. “Proper Calcium Use: Vitamin K2 as a Promoter of Bone and Cardiovascular Health.” Integrative Medicine, 14(1):34-9. (https://pubmed.ncbi.nlm.nih.gov/26770129/)
Transparent Labs. “Vitamin D3 + K2 Benefits: Why They Work Best Together.” (https://www.transparentlabs.com/blogs/all/d3-k2)
SelfHacked. “8 Proven Vitamin K Benefits + Top Food Sources.” (https://selfhacked.com/blog/vitamin-k)
Conly, J.M., Stein, K. “The production of menaquinones (vitamin K2) by intestinal bacteria and their role in maintaining coagulation homeostasis.” Progress in Food & Nutrition Science, 16(4):307-43. (https://pubmed.ncbi.nlm.nih.gov/1492156/)
Rhonda Patrick. “Vitamin K’s Dual Role in Coagulation and Vascular Health.” (https://www.youtube.com/watch?v=3OcsrPkdW3Y)
Neurohacker Collective. “Vitamin K2 (as Vitaquinone® MK-7).” (https://www.qualialife.com/formulation/vitamin-k2-as-vitaquinone-mk-7)
Vos, M., et al. “Vitamin K2 is a mitochondrial electron carrier that rescues pink1 deficiency.” Science, 336(6086):1306-10. (https://pubmed.ncbi.nlm.nih.gov/22582012/)
Nootropics Expert. “Vitamin K2 Myelin & Cell Signaling.” (https://www.youtube.com/watch?v=FPn0_mH3Uk8)
Huang, Z., et al. “Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials.” Osteoporosis International, 26:1175-86. (https://pubmed.ncbi.nlm.nih.gov/25516361/)
Schurgers, L.J., et al. “Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7.” Blood, 109(8):3279-83. (https://pubmed.ncbi.nlm.nih.gov/17158229/)
Kresser, C. “Vitamin K2: The Missing Nutrient.” (https://chriskresser.com/vitamin-k2-the-missing-nutrient/)
Dalmeijer, G.W., et al. “The effect of menaquinone-7 supplementation on circulating species of matrix Gla protein.” Atherosclerosis, 225(2):397-402. (https://pubmed.ncbi.nlm.nih.gov/23062766/)
Knapen, M.H., et al. “Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.” Osteoporosis International, 24(9):2499-507. (https://pubmed.ncbi.nlm.nih.gov/23525894/)
JoinMidi. “What Are the Benefits of D3 and K2? Everything You Need to Know About This Calcium Combo.” (https://www.joinmidi.com/post/benefits-of-d3-and-k2)
Masterjohn, C. “Vitamin D toxicity redefined: vitamin K and the molecular mechanism.” Medical Hypotheses, 68(5):1026-34. (https://pubmed.ncbi.nlm.nih.gov/17145139/)
Transparent Labs. “Vitamin D3 + K2 Benefits: Why They Work Best Together.” (https://www.transparentlabs.com/blogs/all/d3-k2)
Kresser, C. “RHR: Vitamin D: Why a Personalized Approach Is Best.” (https://chriskresser.com/vitamin-d-why-a-personalized-approach-is-best/)
Masterjohn, C. “Vitamin K2 and Undercarboxylated Osteocalcin.” (https://chrismasterjohnphd.com/qa/2023/04/18/vitamin-k2-and-undercarboxylated-osteocalcin-masterjohn-qa-files-313)
Huang, Z., et al. “Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials.” Osteoporosis International, 26:1175-86. (https://pubmed.ncbi.nlm.nih.gov/25516361/)
Shiraki, M., et al. “Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis.” Journal of Bone and Mineral Research, 15(3):515-21. (https://pubmed.ncbi.nlm.nih.gov/10750566/)
Koitaya, N., et al. “Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women.” Journal of Bone and Mineral Metabolism, 32(2):142-50. (https://pubmed.ncbi.nlm.nih.gov/23702931/)
Emaus, N., et al. “Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial.” Osteoporosis International, 21(10):1731-40. (https://pubmed.ncbi.nlm.nih.gov/19937427/)
Westenfeld, R., et al. “Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial.” American Journal of Kidney Diseases, 59(2):186-95. (https://pubmed.ncbi.nlm.nih.gov/22169620/)
Vissers, L.E., et al. “Cardiovascular Diseases and Fat Soluble Vitamins: Vitamin D and Vitamin K.” Journal of Clinical Medicine, 4(8):1481-94. (https://pubmed.ncbi.nlm.nih.gov/26598844/)
SelfHacked. “7 Vitamin K2 Health Benefits + Foods & Deficiency Risks.” (https://selfhacked.com/blog/top-10-science-based-benefits-vitamin-k2)
Healthline. “20 Foods That Are High in Vitamin K.” (https://www.healthline.com/nutrition/foods-high-in-vitamin-k)
Verywell Fit. “Vitamin K1 and K2 for Strong Bones and Healthy Arteries.” (https://www.verywellfit.com/vitamin-k-for-strong-bones-and-healthy-arteries-4094112)
Chen, H., et al. “Nattokinase: production and application.” Applied Microbiology and Biotechnology, 99(3):1333-43. (https://pubmed.ncbi.nlm.nih.gov/25348469/)
Walther, B., et al. “Menaquinones, bacteria, and the food supply: the relevance of dairy and fermented food products to vitamin K requirements.” Advances in Nutrition, 4(4):463-73. (https://pubmed.ncbi.nlm.nih.gov/23858094/)
Keyvan, E., et al. “Vitamins formed by microorganisms in fermented foods: effects on human vitamin status.” Frontiers in Nutrition, 12:1653666. (https://pubmed.ncbi.nlm.nih.gov/41127087/)
Thomas DeLauer. “Kefir as a Vitamin K2 Source.” (https://www.youtube.com/watch?v=fOnh3JS5ZPo)
Neurohacker Collective. “What is Vitamin K2? An Exploration of its Benefits.” (https://www.qualialife.com/what-is-vitamin-k2-an-exploration-of-its-benefits)
McFarlin, B.K., et al. “Oral Consumption of Vitamin K2 for 8 Weeks Associated With Increased Maximal Cardiac Output During Exercise.” Alternative Therapies in Health and Medicine, 23(4):26-32. (https://pubmed.ncbi.nlm.nih.gov/28646812/)
Zhang, Y., et al. “Vitamin K2 Alleviates Insulin Resistance Associated Skeletal Muscle Atrophy via the AKT/mTOR Signalling Pathway.” Journal of Cachexia, Sarcopenia and Muscle, 16(3):e13840. (https://pubmed.ncbi.nlm.nih.gov/40464168/)
Moriya, M., et al. “Vitamin K2 ameliorates experimental autoimmune encephalomyelitis in Lewis rats.” Journal of Neuroimmunology, 170(1-2):11-20. (https://pubmed.ncbi.nlm.nih.gov/16146654/)
Simes, D.C., et al. “Vitamin K as a Diet Supplement with Impact in Human Health: Current Evidence in Age-Related Diseases.” Nutrients, 12(1). (https://pubmed.ncbi.nlm.nih.gov/31947821/)
Ebina, K., et al. “Vitamin K2 administration is associated with decreased disease activity in patients with rheumatoid arthritis.” Modern Rheumatology, 23(5):1001-7. (https://pubmed.ncbi.nlm.nih.gov/23124653/)
Atieh, O., et al. “Vitamins K2 and D3 Improve Long COVID, Fungal Translocation, and Inflammation: Randomized Controlled Trial.” Nutrients, 17(2). (https://pubmed.ncbi.nlm.nih.gov/39861434/)
Kresser, C. “Nutrition for Healthy Skin: Silica, Niacin, Vitamin K2, and Probiotics.” (https://chriskresser.com/nutrition-for-healthy-skin-silica-niacin-vitamin-k2-and-probiotics/)
Qu, Z., et al. “Vitamin K2 Enhances Fat Degradation to Improve the Survival of C. elegans.” Frontiers in Nutrition, 9:858481. (https://pubmed.ncbi.nlm.nih.gov/35495953/)
Thomas DeLauer. “Vitamin K2 Benefits.” (https://www.youtube.com/watch?v=jcsX5FCWQ2o)
Caluwé, A., et al. “Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study.” Nephrology Dialysis Transplantation, 29(7):1385-90. (https://pubmed.ncbi.nlm.nih.gov/24285428/)
Verywell Fit. “The 9 Best Vitamin K Supplements of 2024, According to a Dietitian.” (https://www.verywellfit.com/best-vitamin-k-supplements-7187425)
Healthline. “The Fat-Soluble Vitamins: A, D, E, and K.” (https://www.healthline.com/nutrition/fat-soluble-vitamins)